Physician profile
Conrad Anthony Cox
NPI 1851338941
$26,286.54
in general payments reported to CMS, 2019-2025
38 companies · $2,876 in 2025
The $2,876 reported for 2025 was more than what 86% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,892 · 2020: $4,927 · 2021: $3,110 · 2022: $2,057 · 2023: $1,676 · 2024: $2,748 · 2025: $2,876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,012 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $189 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,012.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $189.34 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14,429.36 | 2019-2025 | Linzess, Viberzi, Creon |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $3,305.98 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Phathom Pharmaceuticals, INC. | $1,749.35 | 2023-2025 | Voquezna |
| Gilead Sciences, INC. | $1,388.67 | 2019-2024 | Livdelzi |
| Janssen Biotech, INC. | $980.02 | 2022-2025 | Stelara, Simponi Aria, Simponi |
| Qol Medical, LLC | $765.77 | 2021-2025 | Sucraid, Sucraid |
| Ardelyx, INC. | $626.74 | 2022-2025 | Ibsrela |
| Madrigal Pharmaceuticals | $370.25 | 2024-2025 | Rezdiffra, Resmetirom |
| Pfizer INC. | $327.53 | 2022-2024 | |
| Aimmune Therapeutics, INC. | $252.53 | 2024-2025 | Zenpep, Vowst |
| Intercept Pharmaceuticals, INC. | $210.15 | 2019-2025 | |
| Echosens North America, INC. | $204.34 | 2021-2023 | Fibroscan |
| Takeda Pharmaceuticals U.S.A., INC. | $185.31 | 2019-2024 | Entyvio, Gattex |
| Redhill Biopharma INC. | $164.82 | 2020-2024 | Talicia, Aemcolo, Movantik |
| Exact Sciences Corporation | $159.50 | 2023-2025 | Cologuard Collection Kit |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $154.00 | 2020-2024 | Suflave |
| Nestle Healthcare Nutrition INC. | $140.19 | 2021-2023 | |
| Endogastric Solutions, INC | $128.52 | 2019 | |
| Celltrion USA INC. | $95.02 | 2024-2025 | Vegzelma |
| Alcresta Therapeutics, INC. | $86.50 | 2022 | |
| Merck Sharp & Dohme LLC | $68.30 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $60.74 | 2020-2022 | |
| Romark Laboratories, Lc | $57.29 | 2019-2020 | |
| Genzyme Corporation | $53.41 | 2022 | |
| W. L. Gore & Associates, INC. | $35.82 | 2020-2023 | Gore Cardioform Septal Occluder |
| Ironwood Pharmaceuticals, INC | $35.56 | 2021 | |
| Ambu INC. | $34.45 | 2020 | |
| Vivus LLC | $34.32 | 2022-2023 | Pancreaze |
| Lexicon Pharmaceuticals, INC. | $24.01 | 2019 | |
| Shire North American Group INC | $23.01 | 2019 | |
| Hologic Sales and Service, LLC | $21.14 | 2022 | |
| Alnylam Pharmaceuticals INC. | $17.99 | 2020 | |
| Celgene Corporation | $17.83 | 2021 | |
| Lucid Diagnostics INC. | $17.13 | 2023 | |
| Shionogi INC | $15.92 | 2019 | |
| Alfasigma USA, INC. | $15.89 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $14.95 | 2025 | Iqirvo |
| Allergan, INC. | $14.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conrad Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.